Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells.

Li, Jie H

Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells. [electronic resource] - The American journal of pathology Sep 2009 - 1124-35 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1525-2191

10.2353/ajpath.2009.090113 doi


Adaptor Proteins, Vesicular Transport--metabolism
Apoptosis--drug effects
CASP8 and FADD-Like Apoptosis Regulating Protein--metabolism
Cathepsin B--metabolism
Cells, Cultured
Chromones--pharmacology
Down-Regulation
Endothelial Cells--drug effects
Enzyme Inhibitors--pharmacology
Fas-Associated Death Domain Protein--metabolism
Humans
Lipopolysaccharides--pharmacology
Morpholines--pharmacology
Myeloid Differentiation Factor 88--metabolism
Phosphatidylinositol 3-Kinases--metabolism
Phosphoinositide-3 Kinase Inhibitors
RNA, Small Interfering
Signal Transduction--drug effects
Umbilical Veins--cytology